IL6 and COVID-19: Another prospective study of 426 patients with moderate COVID-19 presenting to two hospitals in India developed and validated three clinical prediction models (particularly useful for resource-limited settings) using age, sex, SpO2, and either neutrophil to lymphocyte ratio, suPAR, or IL6 levels to identify patients unlikely to need supplemental oxygen and hence suitable for safely discharge and community management (16).